Clinical trial

COVID-19 in Rheumatic Inflammatory Diseases Under Immuno-suppressive Drugs

NCT04530682

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2021-03-05

PhaseN/A

Study timeline

Study start (actual)2021-03-05Date precision: day

Registry last updated2026-06-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Inflammatory Rheumatismunresolved

Interventions

Biological samplesBIOLOGICAL

Sponsors & collaborators

University Hospital, Montpellierlead sponsor

French Society of Rheumatologycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04530682 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.